50 science-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"CNRS" Fellowship positions at New England HERC
Sort by
Refine Your Search
-
, clinicians, and students, and write for peer-reviewed publication. As normally acquired through a doctoral degree (PhD or equivalent) in kinesiology, rehabilitation science, public health, health
-
Boston, Massachusetts, Alnylam - Clinical Science Postdoctoral Research Fellow About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program is a two
-
details visit our website: https://impactclimate.mit.edu/ Candidates must have completed a Ph.D. in a relevant field by the start of the fellowship, should be passionate and informed about climate
-
, petrology, geophysics, oceanography, atmospheric dynamics, climate science, atmospheric chemistry, Earth history, hydrology, mineralogy, mineral physics, paleomagnetism, seismology, and planetary sciences
-
, where you're empowered to push the boundaries of science and unleash your entrepreneurial spirit. It's an opportunity to make a meaningful difference to medicine, patients, and society. We foster an
-
Principal Investigator) and Peter Galison ( BHEX Science Team Lead). The successful candidates will be embedded within the interdisciplinary research environment of the Black Hole Initiative, with the
-
the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of
-
PhD, MD, or other relevant doctoral degrees in economics, political science, statistics, sociology, psychology, social work, psychiatry, public health, or other related fields. The program's goal is
-
, paid time off, tuition assistance, wellness & life, retirement- as well as commuting & transportation. Visit https://hr.northeastern.edu/benefits/ for more information. All qualified applicants are
-
in RNAi therapeutics - a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the